Researchers track immune clues after lung cancer treatment
NCT ID NCT05415358
First seen Feb 03, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study looks at 23 people with metastatic non-small cell lung cancer who have finished at least 20 months of immunotherapy (with or without chemo). Researchers want to see if certain immune markers or DNA in the blood can predict if the cancer will come back. The goal is to better understand who might need more treatment after stopping immunotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER, NONSMALL CELL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Atrium Health Levine Cancer
Charlotte, North Carolina, 28204, United States
-
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.